Fmr LLC Terns Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,767,096 shares of TERN stock, worth $19.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,767,096

Previous 2,762,126 0.18%

Holding current value

$19.6 Million

Previous $18.1 Million 4.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.54 - $8.2 $22,563 - $40,754	4,970 Added 0.18%	2,767,096 $18.8 Million
Q1 2024 May 13, 2024	SELL	$4.86 - $8.19 $1.11 Million - $1.87 Million	-228,276 Reduced 7.63%	2,762,126 $18.1 Million
Q4 2023 Feb 13, 2024	SELL	$3.37 - $6.86 $7.17 Million - $14.6 Million	-2,127,648 Reduced 41.57%	2,990,402 $19.4 Million
Q3 2023 Nov 13, 2023	SELL	$4.7 - $8.55 $9.08 Million - $16.5 Million	-1,932,296 Reduced 27.41%	5,118,050 $25.7 Million
Q2 2023 Aug 11, 2023	SELL	$7.35 - $13.29 $4.35 Million - $7.87 Million	-592,412 Reduced 7.75%	7,050,346 $61.7 Million
Q1 2023 May 11, 2023	BUY	$7.91 - $12.0 $2.09 Million - $3.17 Million	264,117 Added 3.58%	7,642,758 $90.5 Million
Q4 2022 Feb 13, 2023	BUY	$4.62 - $10.18 $33.6 Million - $74.1 Million	7,277,002 Added 7159.66%	7,378,641 $75.1 Million
Q3 2022 Nov 10, 2022	SELL	$1.87 - $6.42 $67 - $231	-36 Reduced 0.04%	101,639 $599,000
Q2 2022 Aug 12, 2022	SELL	$1.5 - $3.0 $3.33 Million - $6.66 Million	-2,219,783 Reduced 95.62%	101,675 $252,000
Q1 2022 May 13, 2022	SELL	$2.83 - $6.7 $1.36 Million - $3.21 Million	-479,527 Reduced 17.12%	2,321,458 $6.9 Million
Q4 2021 Feb 14, 2022	SELL	$5.65 - $10.73 $746,800 - $1.42 Million	-132,177 Reduced 4.51%	2,800,985 $19.8 Million
Q3 2021 Nov 15, 2021	SELL	$7.22 - $13.46 $645,431 - $1.2 Million	-89,395 Reduced 2.96%	2,933,162 $30.6 Million
Q2 2021 Aug 13, 2021	BUY	$12.26 - $22.0 $37.1 Million - $66.5 Million	3,022,557 New	3,022,557 $37.1 Million

Others Institutions Holding TERN

# of Institutions

139

Shares Held

63.8M

Call Options Held

413K

Put Options Held

106K

View Full List

About Terns Pharmaceuticals, Inc.

Ticker TERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,613,800
Market Cap $267M
Description
Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...

More about TERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account